Template:Labeltemplate: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 17: Line 17:
! style="font-size: 80%; padding: 0 5px; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" align=left | [[{{BASEPAGENAME}}/drug interactions|{{fontcolor|#F8F8FF|Drug Interactions}}]]
! style="font-size: 80%; padding: 0 5px; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" align=left | [[{{BASEPAGENAME}}/drug interactions|{{fontcolor|#F8F8FF|Drug Interactions}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" align=left | <div class="mw-customtoggle-box04" style="cursor: pointer; -webkit-user-select: none;">{{fontcolor|#F8F8FF|Use in Specific Populations}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-box04">&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Pregnancy|{{fontcolor|#F8F8FF|Pregnancy}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Labor and Delivery|{{fontcolor|#F8F8FF|Labor and Delivery}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Nursing Mothers|{{fontcolor|#F8F8FF|Nursing Mothers}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Pediatric Use|{{fontcolor|#F8F8FF|Pediatric Use}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Geriatric Use|{{fontcolor|#F8F8FF|Geriatric Use}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Gender|{{fontcolor|#F8F8FF|Gender}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Race|{{fontcolor|#F8F8FF|Race}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Renal Impairment|{{fontcolor|#F8F8FF|Renal Impairment}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Hepatic Impairment|{{fontcolor|#F8F8FF|Hepatic Impairment}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Females of Reproductive Potential and Males|{{fontcolor|#F8F8FF|Females of Reproductive<BR>&nbsp;&nbsp;&nbsp;&nbsp;Potential and Males}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/use in specific populations#Immunocompromised Patients|{{fontcolor|#F8F8FF|Immunocompromised Patients}}]]</div>
! style="font-size: 80%; padding: 0 5px; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" align=left | [[{{BASEPAGENAME}}/use in specific populations|{{fontcolor|#F8F8FF|Use in Specific Populations}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" align=left | <div class="mw-customtoggle-box05" style="cursor: pointer; -webkit-user-select: none;">{{fontcolor|#F8F8FF|Routes and Preparations}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-box05">&nbsp;&nbsp;[[{{BASEPAGENAME}}/routes and preparations#Routes|{{fontcolor|#F8F8FF|Routes}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/routes and preparations#Preparations|{{fontcolor|#F8F8FF|Preparations}}]]</div>
! style="font-size: 80%; padding: 0 5px; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" align=left | <div class="mw-customtoggle-box05" style="cursor: pointer; -webkit-user-select: none;">{{fontcolor|#F8F8FF|Routes and Preparations}}</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-box05">&nbsp;&nbsp;[[{{BASEPAGENAME}}/routes and preparations#Routes|{{fontcolor|#F8F8FF|Routes}}]]<BR>&nbsp;&nbsp;[[{{BASEPAGENAME}}/routes and preparations#Preparations|{{fontcolor|#F8F8FF|Preparations}}]]</div>

Revision as of 01:12, 21 March 2014